Ruxolitinib | compare suppliers & send inquiries for free
Looking for Ruxolitinib 941678-49-5?
Here you will find more information about Ruxolitinib. Ruxolitinib is a janus-associated kinase inhibitor indicated to treat bone marrow cancer, specifically intermediate or high-risk myelofibrosis. FDA approved on November 16, 2011.
More information such as the structure, indication or toxicity is available on Drugbank, click the ID above.
Ruxolitinib manufacturers | traders | suppliers
We have 5 companies offering Ruxolitinib from 2 different countries.
Get in contact with the supplier of your choice:
- MSN Labs. from India
- Apino Pharma Co., Ltd. from China
- Bayee Biotech(Anqing)Co.,Ltd from China
- Shandong Octagon Chemicals Limited from China
- Chongqing Huapont from China
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.